Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

RØNTGEN-ULTRALYDS KLINIKKEN ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.7% 0.7%   Bankruptcy risk   1.3% 2.5% 2.3% 2.7% 3.3% 2.6% 9.8% 9.8%   Credit score (0-100)   82 64 64 59 54 61 25 25   Credit rating   A BBB BBB BBB BBB BBB BB BB   Credit limit (kDKK)   29.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   340 94 84 84 84 77 77 77   Gross profit   238 1.2 -0.5 -46.2 -26.5 -18.3 0.0 0.0   EBITDA   238 1.2 -0.5 -46.2 -26.5 -18.3 0.0 0.0   EBIT   238 1.2 -0.5 -60.6 -41.0 -34.8 0.0 0.0   Pre-tax profit (PTP)   197.8 24.1 13.7 13.3 -176.1 -42.8 0.0 0.0   Net earnings   170.7 18.8 10.7 10.4 -137.3 -33.4 0.0 0.0   Pre-tax profit without non-rec. items   198 24.1 13.7 13.3 -176 -42.8 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   1,977 1,977 1,977 2,008 1,994 1,988 0.0 0.0   Shareholders equity total   1,527 1,437 1,448 1,458 1,321 1,249 1,124 1,124   Interest-bearing liabilities   1,400 1,400 1,400 1,404 1,416 1,416 0.0 0.0   Balance sheet total (assets)   2,971 2,845 2,874 2,862 2,737 2,724 1,124 1,124   Net Debt   435 544 1,135 1,274 1,323 1,388 -1,124 -1,124     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   340 94 84 84 84 77 77 77   Net sales growth   42.2% -72.5% -10.3% 0.0% 0.0% -8.3% 0.0% 0.0%   Gross profit   238 1.2 -0.5 -46.2 -26.5 -18.3 0.0 0.0   Gross profit growth   92.5% -99.5% 0.0% -8,781.0% 42.5% 31.0% 0.0% 0.0%   Employees   0 0 0 0 0 0 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,971 2,845 2,874 2,862 2,737 2,724 1,124 1,124   Balance sheet change%   3.2% -4.2% 1.0% -0.4% -4.4% -0.5% -58.7% 0.0%   Added value   238.0 1.2 -0.5 -46.2 -26.5 -18.3 0.0 0.0   Added value %   70.0% 1.3% -0.6% -55.0% -31.6% -23.8% 0.0% 0.0%   Investments   0 0 0 17 -29 -23 -1,988 0   Net sales trend   2.0 -1.0 -2.0 0.0 0.0 -1.0 0.0 0.0   EBIT trend   2.0 3.0 -1.0 -2.0 -3.0 -4.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   70.0% 1.3% -0.6% -55.0% -31.6% -23.8% 0.0% 0.0%   EBIT %   70.0% 1.3% -0.6% -72.2% -48.8% -45.2% 0.0% 0.0%   EBIT to gross profit (%)   100.0% 100.0% 100.0% 131.3% 154.4% 190.2% 0.0% 0.0%   Net Earnings %   50.2% 20.1% 12.7% 12.3% -163.5% -43.4% 0.0% 0.0%   Profit before depreciation and extraordinary items %   50.2% 20.1% 12.7% 29.5% -146.3% -21.9% 0.0% 0.0%   Pre tax profit less extraordinaries %   58.2% 25.8% 16.3% 15.8% -209.6% -55.6% 0.0% 0.0%   ROA %   8.6% 1.9% 1.4% 1.4% -0.1% 1.2% 0.0% 0.0%   ROI %   8.7% 1.9% 1.4% 1.4% -0.1% 1.2% 0.0% 0.0%   ROE %   11.4% 1.3% 0.7% 0.7% -9.9% -2.6% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   51.4% 50.5% 50.4% 51.0% 48.3% 45.8% 100.0% 100.0%   Relative indebtedness %   425.0% 1,504.3% 1,697.5% 1,671.1% 1,685.4% 1,865.9% 0.0% 0.0%   Relative net indebtedness %   141.1% 589.4% 1,381.9% 1,516.8% 1,575.5% 1,830.4% -1,459.6% -1,459.6%   Net int. bear. debt to EBITDA, %   182.9% 44,633.2% -218,256.0% -2,758.9% -4,987.6% -7,586.4% 0.0% 0.0%   Gearing %   91.7% 97.4% 96.7% 96.3% 107.2% 113.3% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   3.8% 2.2% 1.8% 1.8% 12.2% 5.3% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   22.3 107.7 10.4 35.3 9.2 2.3 0.0 0.0   Current Ratio   22.3 107.7 10.4 35.3 9.2 2.3 0.0 0.0   Cash and cash equivalent   964.8 856.4 265.1 129.6 92.2 27.3 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   8.8 9.7 111.6 0.0 0.0 81.2 0.0 0.0   Current assets / Net sales %   292.5% 927.9% 321.2% 157.3% 171.3% 108.4% 1,459.6% 1,459.6%   Net working capital   406.9 265.3 243.9 128.4 128.2 46.7 0.0 0.0   Net working capital %   119.7% 283.5% 290.4% 152.9% 152.6% 60.7% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 0 0 0   EBIT / employee   0 0 0 0 0 0 0 0   Net earnings / employee   0 0 0 0 0 0 0 0